Jason Kelly
Fortuna: 22 M $ al 31/05/2026
Fortuna: 22 M $ al 31/05/2026
Jason Kelly fundó Ginkgo Bioworks Holdings, Inc. y Ginkgo Bioworks, Inc. En la actualidad, ocupa el cargo de Director General y Director de Ginkgo Bioworks Holdings, Inc. y Director General y Director de Ginkgo Bioworks, Inc. (una filial de Ginkgo Bioworks Holdings, Inc.). El Dr. Kelly también forma parte del consejo de Octant, Inc. y de Motif Food Works, Inc. En su anterior carrera, el Dr. Kelly fue director general y consejero de Soaring Eagle Acquisition Corp. Se licenció y doctoró en el Instituto Tecnológico de Massachusetts.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 15/04/2026 | 2.041.437 ( 22,21 % ) | 19 M $ | 31/05/2026 | |
| 15/04/2026 | 316.483 ( 0,59 % ) | 3 M $ | 31/05/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| GINKGO BIOWORKS HOLDINGS, INC. | Fundador | 01/01/2008 |
Ginkgo Bioworks, Inc.
Ginkgo Bioworks, Inc. Information Technology ServicesTechnology Services Develops biological technology and software solutions | Fundador | 01/01/2008 |
Motif Food Works, Inc.
Motif Food Works, Inc. Food: Major DiversifiedConsumer Non-Durables Operates as a food ingredients company which provides sustainable alternative proteins and ingredient solutions | Director/Miembro de la Junta | - |
Octant, Inc.
Octant, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company | Director/Miembro de la Junta | - |
Gen9, Inc.
Gen9, Inc. BiotechnologyHealth Technology Develops synthetic biology technologies | Director/Miembro de la Junta | - |
NextGen Venture Partners LLC
NextGen Venture Partners LLC Investment ManagersFinance NextGen Venture Partners invests in companies located in the United States with a minimum revenues of USD 10 million. The firm focuses on a broad range of sectors and industries. It provides financing for seed, early and growth stage capital requirements with an investment size of USD 0.5 - 2 million for seed and early stage companies and USD 3 - 5 million for growth stage companies. | Inversor de Capital Privado | - |
| Empresas | Cargo | Fin |
|---|---|---|
| STANDARD BIOTOOLS INC. | Director/Miembro de la Junta | 01/09/2021 |
| GINO BIOW | Director Ejecutivo | - |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 9 |
|---|---|
Gen9, Inc.
Gen9, Inc. BiotechnologyHealth Technology Develops synthetic biology technologies | Health Technology |
Octant, Inc.
Octant, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company | Commercial Services |
Massachusetts Institute of Technology
Massachusetts Institute of Technology Finance/Rental/LeasingFinance Functions as a College/University | Finance |
Ginkgo Bioworks, Inc.
Ginkgo Bioworks, Inc. Information Technology ServicesTechnology Services Develops biological technology and software solutions | Technology Services |
NextGen Venture Partners LLC
NextGen Venture Partners LLC Investment ManagersFinance NextGen Venture Partners invests in companies located in the United States with a minimum revenues of USD 10 million. The firm focuses on a broad range of sectors and industries. It provides financing for seed, early and growth stage capital requirements with an investment size of USD 0.5 - 2 million for seed and early stage companies and USD 3 - 5 million for growth stage companies. | Finance |
Motif Food Works, Inc.
Motif Food Works, Inc. Food: Major DiversifiedConsumer Non-Durables Operates as a food ingredients company which provides sustainable alternative proteins and ingredient solutions | Consumer Non-Durables |
CM Life Sciences II, Inc.
CM Life Sciences II, Inc. Financial ConglomeratesFinance Operates as a blank check company | Finance |
Soaring Eagle Acquisition Corp.
Soaring Eagle Acquisition Corp. Financial ConglomeratesFinance Operates as a blank check company | Finance |
Ginkgo Bioworks Holdings, Inc.
Ginkgo Bioworks Holdings, Inc. Medical/Nursing ServicesHealth Services Develops biological engineering products and custom microbes | Health Services |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.